Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors.

about

Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors.

Item

http://www.wikidata.org/entity/Q36038920

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hypertension and Life-Threaten ...... Treated with FLT3 Inhibitors.

@ast

Hypertension and Life-Threaten ...... Treated with FLT3 Inhibitors.

@en

type

Item

label

Hypertension and Life-Threaten ...... Treated with FLT3 Inhibitors.

@ast

Hypertension and Life-Threaten ...... Treated with FLT3 Inhibitors.

@en

prefLabel

Hypertension and Life-Threaten ...... Treated with FLT3 Inhibitors.

@ast

Hypertension and Life-Threaten ...... Treated with FLT3 Inhibitors.

@en

P1476

Hypertension and Life-Threaten ...... Treated with FLT3 Inhibitors.

@en

P2093

Can Balkan

http://www.w3.org/2001/XMLSchema#string

Deniz Yılmaz Karapınar

http://www.w3.org/2001/XMLSchema#string

Kaan Kavaklı

http://www.w3.org/2001/XMLSchema#string

Nihal Karadaş

http://www.w3.org/2001/XMLSchema#string

Yeşim Aydınok

http://www.w3.org/2001/XMLSchema#string

Zühal Önder Siviş

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.

Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia.

A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.

Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib

Treatment of FLT3-ITD acute myeloid leukemia.

Gene mutations and molecularly targeted therapies in acute myeloid leukemia.

Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

Novel therapies for children with acute myeloid leukaemia.

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.

P304

263-266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

review article

P356

10.4274/TJH.2014.0250

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275526483

http://www.w3.org/2001/XMLSchema#string

P698

25912283

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

acute myeloid leukemia

mechanism of action

arterial hypertension

membrane proteins

hydrocarbon

urea

proto-oncogene proteins

neoplasm proteins

Anzim

P932

4563203

http://www.w3.org/2001/XMLSchema#string